SC 13D/A

AMENDMENT NO. 2 TO SCHEDULE 13D

Company: Milestone Pharmaceuticals Inc.
Filed: November 27, 2019
Accession Number: 0001193125-19-302384

View Document ↗ View on SEC.gov ↗